ENTER MEDITECH IVS: Financial statements 2017
CVR: 36507691
Source: annual report 2017, Danish Business Authority
01/02/2016 – 31/01/2017
ENTER MEDITECH IVS (CVR 36507691) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK -57,812 and a net result of DKK -72,871 compared with DKK -195,886 the year before. Equity in the 2017 report amounted to DKK 143,243. The solvency ratio was 80.9%.
- Revenue
- DKK -57,812
- Gross Profit
- DKK -57,812
- Profit/Loss
- DKK -72,871
- Equity
- DKK 143,243
- Total Assets
- DKK 176,975
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | -58 t. | -58 t. | -73 t. | 143 t. | - |
| 2016 | - | -187 t. | -196 t. | 216 t. | - |
Official annual report
Keep an eye on ENTER MEDITECH IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ENTER MEDITECH IVS has published its annual report for 2016. Gross profit came to DKK -186,542, and the net result was DKK -195,886.
About ENTER MEDITECH IVS
ENTER MEDITECH IVS was a Danish company of the type Iværksætterselskab based in Dronninglund, founded in 2015. The company has been dissolved on 26 February 2020. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -12,439 the year before. Equity in the 2019 report amounted to DKK 130,804.
